MarketCapTrends
XENE

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ

Xenon Pharmaceuticals Inc. annual/quarterly total liabilities history from 2013 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.

  • Xenon Pharmaceuticals Inc. total liabilities for the quarter ending December 31, 2025 were 51.4M, a 18.89% increase year-over-year.
  • Xenon Pharmaceuticals Inc. total liabilities for 2025 were 51.4M, a 18.89% increase from 2024.
  • Xenon Pharmaceuticals Inc. total liabilities for 2024 were 43.2M, a 17.24% increase from 2023.
  • Xenon Pharmaceuticals Inc. total liabilities for 2023 were 36.9M, a 12.95% increase from 2022.
  • Xenon Pharmaceuticals Inc. total liabilities for 2022 were 32.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
Xenon Pharmaceuticals Inc. Annual Total Liabilities (Millions of US $)
2025$51
2024$43
2023$37
2022$33
2021$22
2020$18
2019$56
2017$10
2016$4
2015$3
2014$15
2013$30
Xenon Pharmaceuticals Inc. Quarterly Total Liabilities (Millions of US $)
2025-12-31$51
2024-12-31$43
2023-12-31$37
2022-12-31$33
2021-12-31$22
2020-12-31$18
2019-12-31$56
2017-12-31$10
2016-12-31$4
2015-12-31$3
2014-12-31$15
2013-12-31$30

Xenon Pharmaceuticals Inc. Total Liabilities — FAQ

Xenon Pharmaceuticals Inc. (XENE) total liabilities over the last 13 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see XENE's total liabilities history?

The chart and table above show Xenon Pharmaceuticals Inc.'s total liabilities by year and by quarter, including the growth rate.